Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...
Share on Facebook Share on Twitter Today, we salute Army Veteran Dana Bowman. Dana lost both his legs in a parachuting ...
Share on Facebook Share on Twitter Frustration and tempers are clearly bubbling over amidst relief efforts in North Carolina.
Johnson & Johnson raised its 2024 profit and sales forecasts following strong oncology drug sales, notably Darzalex. Despite ...
The drugmaker met increased demand following approval of Carvykti in earlier lines of therapy with expanded production at US and European facilities.